Mapping cytosine modifications
First Claim
Patent Images
1. A composition comprising a reducing agent capable of converting 5-formylcytosine or 5-carboxycytosine to 5-hydroxymethylcytosine;
- T4 β
-glucosyltransferase (BGT) and a UDP derivative selected from the group consisting of UDP-glucose and UDP-azidoglucose.
3 Assignments
0 Petitions
Accused Products
Abstract
Methods, compositions and kits for selectively altering and detecting modified cytosine residues are provided.
-
Citations
6 Claims
-
1. A composition comprising a reducing agent capable of converting 5-formylcytosine or 5-carboxycytosine to 5-hydroxymethylcytosine;
- T4 β
-glucosyltransferase (BGT) and a UDP derivative selected from the group consisting of UDP-glucose and UDP-azidoglucose. - View Dependent Claims (2)
- T4 β
-
3. A kit comprising a reducing agent capable of converting 5-formylcytosine or 5-carboxycytosine to 5-hydroxymethylcytosine;
- T4 β
-glucosyltransferase (BGT); and
a UDP derivative selected from the group consisting of UDP-glucose and UDP-azidoglucose. - View Dependent Claims (4, 5, 6)
- T4 β
Specification